Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ghrelin and hypothalamic development: too little and too much of a good thing
Jenny Tong, David D’Alessio
Jenny Tong, David D’Alessio
Published January 20, 2015
Citation Information: J Clin Invest. 2015;125(2):490-492. https://doi.org/10.1172/JCI79187.
View: Text | PDF
Commentary

Ghrelin and hypothalamic development: too little and too much of a good thing

  • Text
  • PDF
Abstract

Neural centers in the hypothalamus regulate food intake and body weight in response to hormones and other neural stimuli, and dysfunctional communication between the brain and gut underlies metabolic disorders, including obesity. In this issue of the JCI, Steculorum and colleagues present evidence that the gastric peptide ghrelin mediates neural fiber growth in the arcuate nucleus of the hypothalamus during the neonatal period. Neonatal mice subjected to either increased or decreased ghrelin action during this developmental period had an increased risk of obesity in adulthood. Together, the results of this study support a model whereby neural organization at key stages of development sets the foundation for metabolic health later in life.

Authors

Jenny Tong, David D’Alessio

×

Figure 1

Alterations in ghrelin levels during the neonatal period promote metabolic dysfunction in adulthood.

Options: View larger image (or click on image) Download as PowerPoint
Alterations in ghrelin levels during the neonatal period promote metabol...
When ghrelin is antagonized or removed, there is an increase in neuronal projections from the ARH to the PVN, with a predominance of projections from orexigenic AgRP/NPY neurons. Exposure to exogenous ghrelin in the neonatal period results in a reduction of neuronal connections between the ARH and PVN; however, were there is still a predominance of AgRP/NPY projections. Ghrelin may exert its trophic effect on hypothalamic neurons via leptin and/or through direct interaction with neurons within the ARH. The net effect of altered ghrelin signaling during development is a positive energy balance and glucose intolerance in adulthood.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts